# Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions

> **NCT06441539** · NA · NOT_YET_RECRUITING · sponsor: **Yinyi(Liaoning) Biotech Co., Ltd.** · enrollment: 218 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Bingo® Paclitaxel coated balloon
- **DEVICE:** Xience® Alpine Everolimus Eluting Coronary Stent System

## Key facts

- **NCT ID:** NCT06441539
- **Lead sponsor:** Yinyi(Liaoning) Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2025-02-28
- **Final completion:** 2026-05-31
- **Target enrollment:** 218 (ESTIMATED)
- **Last updated:** 2024-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06441539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06441539, "Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT06441539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*